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Abstract
Background: Moral Reconation Therapy (MRT) is a cognitive-behavioral intervention aimed at reducing risk for
criminal recidivism by restructuring antisocial attitudes and cognitions (i.e., “criminogenic thinking”). MRT has
empirical support for reducing risk for criminal recidivism among civilian offenders. Recently, a version of MRT
was developed for military veterans; however, no randomized controlled trials (RCT) have been conducted
with the veteran-specific protocol, and the effectiveness and implementation potential of MRT outside of correctional
settings has not been established.
Methods: Using a Hybrid Type 1 RCT design, this study will test the effectiveness of MRT to reduce risk for criminal
recidivism and improve health-related outcomes among justice-involved veterans entering mental health residential
treatment at three US Veterans Health Administration (VHA) Medical Centers. Upon admission to the treatment program,
justice-involved veterans will complete a baseline assessment, be randomized to usual care (UC) or UC +MRT, and be
followed 6 and 12 months post-baseline. A process evaluation will also be conducted to identify barriers and facilitators
to implementation of MRT in residential treatment.
Discussion: The primary aim of this study is to evaluate the effectiveness of MRT with justice-involved veterans. If MRT
proves effective in this trial, the findings can provide large healthcare systems that serve veterans with an evidence-based
intervention for addressing criminogenic thinking among justice-involved adults, as well as guidance on how to facilitate
future implementation of MRT in non-correctional settings.
Trial registration: This trial is funded by the VA Health Services Research & Development Program (IIR 14–081) and is
registered with ClinicalTrials.gov (ID: NCT02524171).
Keywords: Moral Reconation therapy, Justice-involved veterans, Randomized controlled trial, Veterans health
administration, Hybrid trial, Effectiveness, Implementation
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Background
Among criminal offenders, two-thirds will recidivate
(i.e., be rearrested, reconvicted, or reincarcerated for a
new crime or violation of their parole or probation)
within 3 years from their release [1]. Criminal recidivism
is also common among veterans of the US military
(“justice-involved veterans”), who comprise 8% of the in-
carcerated population in the US (approximately 181,500
individuals). For example, the majority of incarcerated
veterans in US jails and prisons have at least one prior
episode of incarceration, and 43% have four or more
prior lifetime arrests [2]. Therefore, there is a critical
need to develop and test interventions that may reduce
criminal recidivism in this population.
According to the Risk-Need-Responsivity model of
offender rehabilitation, antisocial cognitions and atti-
tudes – referred to as criminogenic thinking – are the
risk factors most strongly associated with criminal recid-
ivism [3, 4]. Criminogenic thinking has also been linked
to offending among US military veterans [5–9]. Cognitive-
behavioral interventions that are designed to restructure
antisocial cognitions and behaviors represent best prac-
tices for reducing criminal recidivism [10–13]. However,
the availability of these interventions for justice-involved
veterans following release from correctional settings is less
than the availability of services to address other risk fac-
tors for recidivism identified in the Risk-Need-
Responsivity model – e.g., substance abuse [14].
Moral Reconation Therapy (MRT) is a cognitive-
behavioral intervention that aims to reduce criminogenic
thinking [15] and has the strongest empirical support for
reducing criminal recidivism among civilian offenders
[8]. MRT is a manualized intervention that uses an
open-enrollment, group format and includes a patient
workbook. The MRT curriculum consists of structured
exercises and homework assignments that aim to modify
the antisocial cognitions and behaviors of participants in
order to move them through 12 steps of moral develop-
ment. The term “conation” has been employed to
describe the conscious process of decision-making and
purposeful behavior. The term “moral reconation” was
chosen for this treatment approach because the under-
lying goal is to change conscious decision-making to
higher levels of moral reasoning [16].
Multiple meta-analyses in civilian populations support
the efficacy of MRT to reduce criminal recidivism [10,
11, 17–20]. For example, in a review of 65 studies, MRT
was found to reduce the 12-month recidivism rate by
50% [20]. More recently, a meta-analysis of 33 published
studies of MRT found that the rate of recidivism among
MRT participants is reduced by one-third compared to
the rate of those who do not receive MRT and that the
treatment effect size is greater in randomized (vs. non-
randomized) trials. Further, a structured evidence review
from the US Department of Veterans Affairs examined
the evidence base for MRT in civilian samples [8]. Six
studies were identified as being rigorous enough to pro-
vide interpretable evidence about the impact of MRT
and all demonstrated a significant reduction in reoffend-
ing in the MRT group [21–26].
Aside from reductions in criminal recidivism, MRT
has theoretical and empirical associations with improve-
ment in several health-related outcomes such as sub-
stance use [21, 27], mental health [28–30], housing [31],
and employment [21]. The theoretical and empirical
links between MRT and these health-related outcomes
are important, given that these health-related out-
comes are risk factors for future recidivism, and im-
provements in these outcomes have been shown to
reduce recidivism. For example, according to the
Risk-Need-Responsivity model [32], substance use and
employment problems are robust predictors of crim-
inal recidivism and are key domains measured by
valid indices of recidivism risk [33].
Despite its evidence base in civilian samples, no
randomized controlled trials (RCT) of MRT have been
conducted with justice-involved veterans. This is an im-
portant research gap as justice-involved veterans differ
from justice-involved civilians on sociodemographics
(justice-involved veterans tend to be older, more edu-
cated, and more likely to be married) [34, 35], offense
characteristics (justice-involved veterans are more likely
to have committed violent offenses, particularly intimate
partner violence) [34–36], mental and physical health
problems (justice-involved veterans have more service-
related traumas and traumatic brain injuries) [37, 38],
and interpersonal problems (a strong connection to mili-
tary culture in veterans can increase feelings of estrange-
ment from social networks upon return to civilian life)
[39]. Given these differences, prior research on MRT
with civilian populations may not be generalizable. In re-
sponse to this gap in the literature, a version of MRT
specific to justice-involved veterans was developed in
2013 [16]; however, its efficacy with this group of of-
fenders has yet to be examined.
Another issue is that MRT was originally developed
for use within correctional settings in which treatment
can be mandated and rewards and sanctions for treat-
ment engagement or non-engagement, respectively, can
be applied. Consequently, knowledge regarding the ef-
fectiveness and implementation potential of MRT in
non-correctional settings is limited. Understanding the
implementation of MRT in non-correctional settings is
important given the rise of diversion programs and spe-
cialty courts in the US over the past decade [40]. More-
over, mental health services are increasingly called upon
to treat criminal offenders and reduce their risk for
criminal recidivism. However, there is a lack of data on
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the effectiveness and implementation potential of MRT
within mental health treatment programs. To fill this gap
in the literature, the study described in this protocol paper
aims to evaluate the effectiveness and implementation po-
tential of MRT for veterans in mental health residential
treatment programs within the US Veterans Health Ad-
ministration (VHA) – a large, integrated healthcare system
which provides mental health and psychosocial services to
a substantial number of justice-involved veterans [41–43].
Method/design
Study design
This study will use a Hybrid Type 1 design [44], which
is a mixed-methods design that will allow us to test the
effectiveness of MRT in an RCT across three VHA med-
ical centers, as well as gather qualitative data on MRT’s
implementation potential in a process evaluation. The
overarching objective of the current study is to evaluate
MRT as an intervention to reduce risk for criminal re-
cidivism and improve health-related outcomes among
justice-involved veterans in VHA mental health residen-
tial treatment programs. At each study site, veterans
who (a) are entering a mental health residential treat-
ment program, and (b) had been arrested and charged
and/or released from incarceration in the past 5 years
will be recruited for participation and randomly assigned
to one of two conditions: usual care (UC) or UC + two
MRT group meetings per week for 12 weeks.
The specific aims of this study are to determine
whether adding MRT to usual care in mental health resi-
dential treatment reduces overall risk for criminal recid-
ivism (Aim 1, Hypothesis 1a); improves health-related
outcomes that are risk factors for recidivism (i.e., sub-
stance use, mental health, housing, and employment
problems) (Aim 1, Hypothesis 1b); and whether the ef-
fects of MRT on reduced recidivism risk and better
health-related outcomes is mediated in part by greater
likelihood of completing the residential treatment pro-
gram and utilizing substance use disorder/mental health
continuing care services (Aim 1; Hypothesis 1c). Patients
will be followed 6 and 12 months post-baseline. The
process evaluation will entail qualitative interviews with
mental health treatment program providers and patients
(Aim 2). The goal of this aim is to inform the future im-
plementation of MRT in VHA by identifying barriers
and facilitators to implementation in residential treat-
ment programs.
In addition to these aims, the study design will also
allow us to explore other mediators and moderators of
MRT’s effects. For example, improvements in interper-
sonal functioning and reductions in affiliations with anti-
social/substance-using peers are key mechanisms of
MRT. Therefore, we will examine if these variables me-
diate links between receipt of MRT and better outcomes
during the follow-up period. Finally, given that (a) psy-
chopathic personality traits have been found to moder-
ate recidivism among justice-involved adults [45], and
(b) patients in this trial will have varied histories of
criminal justice involvement, we will explore whether
level of psychopathy and criminal history at baseline
moderate MRT’s direct effects on outcomes.
Setting
To increase the generalizability of findings, participants
will be drawn from mental health residential treatment
programs at three large VHA Medical Centers on the
West Coast, Midwest, and East Coast of the US. These
residential programs are analogous to the settings in
which MRT was originally developed (i.e., drug thera-
peutic communities in prison) and serve a high propor-
tion of justice-involved veterans who have extensive
histories of criminal justice involvement [46].
Participants
Veteran patients who (a) are entering a mental health
residential treatment program at one of the participating
sites, (b) had been arrested and charged and/or released
from incarceration in the 5 years prior to their current
admission to residential treatment, and (c) are conver-
sant in English will be eligible for participation and re-
cruited into the RCT portion of the study. Exclusion
criteria are being too cognitively impaired to understand
the informed consent process and other study proce-
dures, and pregnancy. Power analyses were calculated to
determine the sample size needed to obtain a small-to-
medium effect size (i.e., f2 = .07) with 80% power. To
account for having patients at three sites, the analyses
were based on six cells (two conditions per site). Based
on an alpha of .05 (two-tailed), the inclusion of three
moderator variables and three interaction terms, and an
expected attrition rate of 20% at the follow-up assess-
ments, a total of 365 patients will need to be recruited
into the study. The sample will be stratified by site such
that 122 patients (with rounding) will be recruited from
each of the three VHA medical centers, with 61 patients
entering each condition at each site.
For the process evaluation (Aim 2), we will interview
six staff members from the mental health residential
treatment programs at each site who were involved in
the delivery and/or implementation of MRT. We will
also conduct interviews with 12 veteran participants
from each site who were randomized to the MRT condi-
tion: one-half will be drawn from those who remained
engaged in MRT during their stay in the residential pro-
gram, and the other half from those who dropped out of
MRT prior to being discharged from the residential pro-
gram. Staff interviews will take place after all patient par-
ticipants have completed the intervention phase of the
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RCT. Patient interviews will take place after participants
have either completed or dropped out of the intervention.
Recruitment for RCT
Veteran patients entering mental health residential treat-
ment programs at participating sites will be screened by
treatment program staff in consecutive order during the
admissions process to determine their eligibility for the
RCT. Treatment program staff members will also verify
that the veteran is not pregnant and is conversant in
English. Treatment program staff will then ask eligible
patients for permission to be contacted about the study
and will provide study personnel with the names and
contact information of eligible patients.
Eligible patients will be contacted by study personnel,
who will explain the purpose of the study, what study
participation would involve, and the risks and benefits of
participation. Patients will be informed that they will be
assigned either to “usual care” or two additional one-
hour long group sessions per week in the residential
treatment program. Regardless of their group assign-
ment, patients will also be informed that they will be
asked to complete an in-person baseline assessment and
two follow-up assessments (in-person or via phone) 6
and 12 months later. Patients who express interest in
participating will be scheduled for the baseline assess-
ment. At the beginning of that assessment, patients will
be screened for cognitive impairment using the Montreal
Cognitive Assessment’s section on Orientation [47].
Patients who are not able to correctly answer the
Orientation (date, location) items will be deemed too
cognitively impaired to understand the study’s proce-
dures, participate meaningfully in MRT, and respond to
interviews, and therefore will be ineligible. For those
who are eligible, written informed consent will be ob-
tained, and the baseline assessment will be administered.
Randomization
At the beginning of the study before participants are re-
cruited, a randomization schedule will be established for
each site using www.randomizer.org. Randomization will
occur in fixed block sizes of six to assure a roughly equal
balance of participants in the two conditions in case the
study does not fully accrue. The schedule concealment
will be maintained by the principal investigator at each
study site. At each site, after creation of the randomization
spreadsheets, sealed envelopes will be labeled with a
unique study ID number and include the condition as-
signment based on the randomization spreadsheet. Fol-
lowing completion of the baseline assessment, the
research assistant will open the envelope for that unique
study participant, notify the participant of his/her group
assignment, and schedule the first MRT session for those
randomized to that condition. Patients randomized to the
UC condition will be asked to not seek out MRT during
the 12-month study period. To reduce contamination,
patients in the UC condition will not be allowed to attend
MRT sessions, and the MRT group facilitators will remind
the members at the end of each session not to discuss the
group content outside of the session. In the event the
study team learns that MRT-related information was
shared with UC participants, the records of those UC
participants will be flagged, and contamination-adjusted
intention-to-treat analyses will be calculated (see Data
analysis section) [48].
Usual care
All patients, regardless of condition, will receive usual
care in the mental health residential treatment program
at one of the three sites. Mental health residential treat-
ment programs serve veterans dealing with homeless-
ness, substance abuse, and/or mental health issues.
These programs aim to improve veterans’ health and fa-
cilitate community reintegration by providing care in a
structured residential environment. The residential pro-
grams are comparable across sites in terms of program
structure and services delivered (patients are involved in
therapeutic activities 7 h per day, 5 days per week), clin-
ical approaches (individual and group-based, cognitive-
behavioral programming for substance use and mental
health problems) and staffing (psychiatrists, psychologists,
social workers, nurses, addiction therapists, vocational
therapists, homelessness coordinators). The participants’
health care providers in the residential treatment pro-
grams (not the study team) will be providing usual care.
No standard treatment will be withheld.
Intervention
Patients assigned to the MRT condition will receive
usual care in the residential treatment program plus 2 h
of MRT weekly. Over the course of 12 weeks, they will
attend 24 group sessions (one-hour sessions, twice per
week). The overall length of the intervention (12 weeks)
corresponds to the national average of bed days of care
for veterans in mental health residential treatment
(3 months) and the minimum intended length of stay for
the target residential programs in this study. Regardless
of patients’ length of stay, continuing care services
are available at the residential programs at each site,
and those who have not yet completed the full MRT
protocol when they discharge from the residential
programs will be encouraged to continue with the
intervention as outpatients.
The MRT curriculum consists of short assignments,
grounded in cognitive-behavioral techniques, which
move participants through 12 steps that aim to restruc-
ture antisocial cognitions and behaviors. To progress
through the steps, patients complete homework between
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group meetings and then present their homework to
group members in the following week’s meeting for
feedback. Participants move through steps at a rate of
approximately 1–2 sessions and group sessions can in-
corporate new members at any time. With open enroll-
ment, patients are presenting on different steps, which is
advantageous because those who have progressed farther
are able to share their insights to newer patients who are
at lower steps. To facilitate patients’ engagement in
MRT, small reinforcements (coins and certificates) will
be offered for completion of key steps in the MRT cur-
riculum (i.e., Steps 3, 7, and 12).
To assess ongoing fidelity to the MRT condition, at
each site, one group session per month will be observed
in-person by study research staff and evaluated against a
fidelity checklist that has been used in prior research
with MRT. The completed fidelity checklists for each
site will then be reviewed each month by the site PIs
and discussed on a monthly treatment fidelity call with
the developers of MRT who will provide corrective feed-
back and consultation to the MRT group facilitators. A
subset of group sessions will also be audio- or video-
recorded (with participant consent) to permit evaluation
of inter-rater reliability of the checklist coding.
Data collection
RCT. For the RCT, research assistants will collect data
from patients at three time-points: baseline, and 6 and
12 months post-baseline. The baseline assessment will
be conducted in-person approximately 1 week after the
patient is admitted to the residential treatment program.
The 6- and 12-month follow-up assessments will be
conducted either in-person or via telephone. We will
use an intent-to-treat design and follow all patients
who are randomized to either the UC or MRT condi-
tion. An overview of the variables that will be mea-
sured across the study time-points and the specific
measures or data sources used to index these vari-
ables are shown in Table 1. Collectively, the measures
represent validated tools that have been commonly
used in prior studies of criminal justice and/or
substance-using populations. With exception of the
Triarchic Psychopathy Measure, all measures will be
administered at all time-points.
Outcome selection was guided by Risk-Need-
Responsivity framework [3, 4], which describes the most ro-
bust risk factors for criminal recidivism, as well as Fon-
taine’s work on homelessness and recidivism [49, 50]. The
primary outcome of recidivism risk will be measured with
the Psychological Inventory of Criminal Thinking Styles
[51], a self-report measure used to assess antisocial cogni-
tions and behaviors (i.e., “criminogenic thinking”). Items on
this measure are summed to create a General Criminal
Thinking score, which has been validated as an overall
index of recidivism risk [52, 53]. Although reductions in
criminal recidivism is the ultimate goal of MRT, given the
non-correctional setting, as well as the fact that patients in
this trial will have varied histories of criminal justice in-
volvement, it is anticipated that the base rate of criminal re-
cidivism will be low during the 12-month follow-up period.
Therefore, we elected to focus on recidivism risk as the
primary outcome and to index this outcome via a
measure of criminogenic thinking, given it is the stron-
gest dynamic risk factor for recidivism [3, 4].
Table 1 Variables and measures/data sources for the randomized controlled trial
Variables Measures/data source
Recidivism risk (overall) Psychological Inventory of Criminal Thinking Styles
Substance use ASI Alcohol and Drug modules
Timeline Follow-back Interview (alcohol and drug use calendars)
Mental health ASI Psychiatric Status module (Global)
Patient Health Questionnaire-9 (Major Depression symptoms)
PTSD Checklist-DSM-5 version (PTSD symptoms)
Housing VHA’s Homeless Operations Management and Evaluation System
Employment ASI Employment/Support module
Completion of the mental health residential treatment program VHA administrative records
Substance use disorder/mental health continuing care utilization VHA administrative records
Alcoholics Anonymous Interview
Interpersonal functioning ASI Family/Social module
Inventory of Interpersonal Problems
Antisocial/substance-using peer affiliations Measure of Criminal Attitudes and Associates
Life Stressors and Social Resources Inventory
Psychopathic personality traits Triarchic Psychopathy Measure *
Criminal history/recidivism ASI Legal Status module
Notes. * = only administered at baseline (all other measures will be administered at all time-points – baseline, 6 months, and 12 months). ASI = Addiction Severity
Index. VHA = Veterans Health Administration
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Secondary outcomes include health-related outcomes
of substance use (via the Alcohol and Drug modules of
the Addiction Severity Index [ASI] [54], and Timeline
Follow-back interviews for alcohol and drug use) [55],
mental health (via the Psychiatric Status section of the
ASI to index global mental health, the Patient Health
Questionnaire-9 to index symptoms of major depression
[56], and the PTSD Checklist, DSM-5 version to index
symptoms of PTSD [57]), housing (via items from the
VHA’s Homeless Operations Management and Evalu-
ation System) [58], and employment (via the Employ-
ment/Support section of the ASI).
In order to test whether the effects of MRT on re-
duced recidivism risk and better health-related outcomes
are mediated in part by greater likelihood of completing
the mental health residential treatment program and
utilizing substance use disorder/mental health continu-
ing care services, we will also collect data on service
utilization (via patients VHA administrative records) and
mutual-help group attendance (via the Alcoholics An-
onymous Interview [59]). In order to conduct explora-
tory mediation analyses, we will measure interpersonal
functioning (via the Family/Social functioning module of
the ASI and the Inventory of Interpersonal Problems
[60]) and antisocial/substance-using peer affiliations (via
select items from the Measures of Criminal Attitudes
and Associates [61] and the Life Stressors and Social Re-
sources Inventory [62]) to test whether changes in these
measures mediate links between receipt of MRT and bet-
ter outcomes during the follow-up period. To conduct
exploratory moderation analyses, we will collect infor-
mation on psychopathic personality traits (via the
Triarchic Psychopathy Measure [63] and criminal history
(via the Legal Status module of the ASI) to test whether
scores on these indices at baseline moderate MRT’s dir-
ect effects on outcomes. The ASI Legal Status module
will also be used to measure criminal recidivism during
the follow-up period.
Process evaluation
The RE-AIM (Reach, Effectiveness, Adoption, Imple-
mentation, and Maintenance) Planning Tool [64] will be
used to guide the content of the semi-structured phone
interviews with mental health residential treatment pro-
gram providers and patients at each site. The RE-AIM
framework [65] highlights five domains to evaluate an
intervention’s potential for implementation and wide-
spread impact: Reach (how to reach the target popula-
tion with the intervention); Effectiveness (how to know
the intervention is effective); Adoption (organizational
support to implement an intervention); Implementation
(fidelity and consistency of an intervention’s delivery);
and Maintenance (sustainability of an intervention in
the long-term). The RE-AIM Planning Tool will be
modified to ask questions of providers and patients
within these domains regarding key issues that should
be considered when planning to implement MRT in
mental health residential treatment across VHA.
Data analysis
RCT
Intent-to-treat analyses will be conducted. The primary
and secondary outcomes will be measured at all three
time-points. Therefore, we will use generalized linear
mixed model (GLMM) regressions to compare the UC
and MRT conditions on these outcomes. These models
take into account that the repeated measures across time
points are clustered within each individual by treating
time as a single repeated factor. GLMMs also have the
advantages of being able to use all available data (under
the assumption that data are missing at random) and
being able to accommodate different conditional distri-
butions for outcome variables (e.g., dichotomous; con-
tinuous; Poisson-distributed). We will also examine
these outcomes as a function of MRT dose (i.e., number
of group sessions attended; number of steps completed).
To test mediation, we will conduct GLMM regressions
following the approach of Mackinnon and Fairchild [66],
which will correspond to a causal sequence among con-
dition, the hypothesized mediator, and the outcomes,
and control for covariates (e.g., baseline scores on the
outcome). To test moderation, we will explore whether
at baseline various indices of criminal history (i.e., incar-
cerated or not in the past 12 months; number of months
since charged with an offense or released from incarcer-
ation; and extent of criminal history) and psychopathic
personality traits moderate the direct effects of condition
on the primary and secondary outcomes. Finally, to ad-
dress the possibility of contamination, if we learn that
MRT-related information was shared with UC partici-
pants, the records of those UC participants will be
flagged, and contamination-adjusted intention-to-treat
analyses will be calculated [48] (i.e., the effect of treat-
ment assignment on outcomes is adjusted by the per-
centage of participants assigned to the UC condition
who may have received the treatment).
Process evaluation
The de-identified audio-files of the staff and patient in-
terviews will be transcribed. The interview transcripts
will then be will be analyzed using template analysis to
identify common themes in textual data [67]. This ap-
proach allows for identification of codes a priori, as well
as modification of codes and addition of new codes
based on a reading and interpretation of the data. This
process will be used to identify themes related to bar-
riers and facilitators to MRT implementation at the sys-
tem, provider, and patient levels. These barrier and
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facilitator themes will be summarized and categorized
into tables, which will include potential solutions and
potential-to-leverage columns that contain evidence-
based implementation tools to be considered for more
widespread usage of MRT.
Ethical considerations
This study was reviewed and approved by the VA’s Central
IRB (Study #15–04) and registered with ClinicalTrials.gov
(ID: NCT02524171). Prospective participants will be told
that they may withdraw from the study at any time and re-
frain from answering specific questions, and that all infor-
mation will be confidential and used only for the purposes
of the research study. Prospective participants will also be
told that any withdrawal from the study on their part or
on the part of the investigators will not affect the standard
care that the participant is receiving in the residential
treatment program or any other healthcare from the VHA
to which the participant is entitled.
Discussion
The primary aim of this hybrid trial is to evaluate the ef-
ficacy of MRT with justice-involved veterans using the
new veteran-specific protocol of this intervention [16].
Another key contribution of this trial is the opportunity
to learn about factors that may either hinder or facilitate
implementation of MRT in a non-correctional setting.
As noted above, MRT was originally developed for use
within correctional settings. Thus, knowledge of the im-
plementation potential of MRT in large, integrated
healthcare systems such as the VHA is limited, and
unique challenges to (or opportunities for) implementa-
tion of MRT in this setting may emerge in this trial. This
issue is timely, given that recent policy efforts in the US
that are focused on diversion rather than incarceration
(e.g., specialty courts) have shifted the burden of treating
justice-involved adults and reducing their risk for recid-
ivism from correctional services to behavioral health
services in the community [40].
Recent work by Blonigen and colleagues [68] high-
lights a number of potential challenges to implementa-
tion of MRT in the VHA. One such challenge that is
relevant to the current trial is patient engagement, given
the time commitment involved in MRT. Specifically, the
MRT curricula and homework assignments that patients
are required to complete between group sessions can be
time intensive, and completion of all 12 MRT steps
requires at least 24 sessions, on average. Consequently,
engagement may be challenging for non-incarcerated
populations. This may be due to the fact that for those
who are not incarcerated or are not mandated to attend
MRT by the criminal justice system, there are no
consequences for not engaging in the intervention. In
addition, those who are not incarcerated may have other
demands on their time such as employment and/or
other treatment requirements placed on them by the
criminal justice system or the residential program in
which MRT has been implemented. We will address this
issue by offering reinforcements (coins and certificates)
for completion of key steps in the MRT curriculum (e.g.,
Steps 3, 7, and 12). For patients who are still under
supervision of the criminal justice system, such incen-
tives are often highly valued as it allows them to demon-
strate to court-related decision makers that they are
complying with treatment [69, 70]. In addition, there is
evidence to suggest that completion of the first seven of
the 12 steps in MRT is associated with long-term reduc-
tions in criminal recidivism [71, 72]. This suggests that a
lower dose than the 24 sessions that are planned for pa-
tients randomized to MRT in this trial may still yield ben-
efits on the primary and secondary outcomes. We
estimate 12 sessions as the minimal dose of MRT for this
study. To maximize the clinical usefulness of the data, our
analytic plan includes an examination of the effect of con-
dition on outcomes as a function of (a) number of MRT
group sessions attended, and (b) number of MRT steps
completed. Finally, the potential challenges of patient en-
gagement in MRT in non-correctional settings and how
to properly incentivize participation (or sanction non-
participation) will be a key focus of the process evaluation,
which will entail interviews with patients who did or did
not remain engaged in MRT during their residential stay.
This hybrid trial represents the first attempt to system-
atically evaluate the effectiveness of MRT with justice-
involved veterans and the implementation potential of this
intervention in a large, integrated healthcare setting. The
potential impact of this work is underscored by the exten-
sive criminal histories of veterans treated in mental health
residential treatment programs in VHA [46] and the
dearth of empirically-supported treatments in this health-
care system that directly address criminogenic thinking
[14] – the strongest dynamic risk factor for criminal recid-
ivism [3, 4]. By testing and implementing MRT in residen-
tial treatment programs, where many patients have
extensive criminal histories, integrated healthcare systems
such as the VHA can better understand how to reduce
risk for criminal recidivism among patients with criminal
justice system involvement and in turn improve the long-
term health and well-being of this vulnerable population.
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